A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

JS015 will be administered intravenously (IV) on days 1 and 15 every 28 day cycle, or day 1 every 21 day cycle, based on different combined chemotherapy.

Toripalimab will be administered intravenously (IV) on day 1 every 21 day cycle.

Paclitaxel will be administered intravenously (IV) on day 1 every 21 day cycle.

Irinotecan will be administered intravenously (IV) on days 1 and 15 every 28 day cycle.

Capecitabin will be administered orally twice daily from day 1 to 14 every 21 day cycle.

Oxaliplatin will be administered intravenously (IV) on day 1 every 21 day cycle.

Bevacizumab of 5mg/kg will be administered intravenously (IV) on days 1 and 15 every 28 day cycle, or7.5mg/kg on day 1 every 21 day cycle, based on different combined chemotherapy.

Fluorouracil will be administered intravenously (IV) on days 1 and 15 every 28 day cycle.

Leucovorin will be administered intravenously (IV) on days 1 and 15 every 28 day cycle.

Gemcitabine will be administered intravenously (IV) on days 1 and 8 every 21 day cycle.

Albumin-bound paclitaxel will be administered intravenously (IV) on days 1 and 8 every 21 day cycle.